Status: Recruiting
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
The purpose of this research is to determine whether a 16-week virtually supervised aerobic and resistance exercise program is feasible in patients receiving first-line chemotherapy after surgery for ovarian or endometrial cancer and if it will improve lower extremity function (function of the legs), lessen chemotherapy-induced peripheral neuropathy (CIPN; numbness or tingling in the hands or feet), and if there is any effect on inflammatory blood markers (the level of a certain marker in the blood that is associated with inflammation; redness and swelling).
Participants needed: 30
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Dana-Farber Cancer InstituteUpdated: Feb 19, 2026Locations: 1
Eligibility criteria
Newly diagnosed patients with stages III-IV ovarian or endometrial cancer [+6]
Pre-existing musculoskeletal, neurological, or cardiorespiratory conditions, as... [+3]